CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Pinion John Richard See Remarks | Grant or award | +4,636 | 56,435 | ||
| 2021-03-01 | Pinion John Richard See Remarks | Sale | −6,198 | $138.17 | $856K | 50,237 |
| 2021-03-01 | Pinion John Richard See Remarks | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2021-03-01 | Parschauer Karah Herdman EVP and General Counsel | Grant or award | +5,500 | 29,561 | ||
| 2021-03-01 | Parschauer Karah Herdman EVP and General Counsel | Grant or award | +4,636 | 34,197 | ||
| 2021-03-01 | Parschauer Karah Herdman EVP and General Counsel | Sale | −3,970 | $138.17 | $549K | 30,227 |
| 2021-03-01 | Parschauer Karah Herdman EVP and General Counsel | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2021-03-01 | Huizenga Theodore Alan SVP, Controller and PAO | Grant or award | +1,560 | 17,276 | ||
| 2021-03-01 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −732 | $138.17 | $101K | 16,544 |
| 2021-03-01 | Huizenga Theodore Alan SVP, Controller and PAO | Grant or award · Stock Option (Right to Buy) | +4,655 | 4,655 |
Page 21 of 21 · 410 trades